Psychosocial and cognitive rehabilitation of patients with solvent-induced chronic toxic encephalopathy: A randomised controlled study

Psychotherapy and Psychosomatics

Volumn 77, Issue 5, 2008, Pages 289-297

  Van Hout, Moniek S E ^a   Wekking, Ellie M ^b,c   Berg, Ina J ^d   Deelman, Betto G ^d  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Brain diseases, chemically induced; Brain diseases, rehabilitation; Chronic toxic encephalopathy; Malingering; Solvents, toxicity; Treatment outcomes

Indexed keywords

SOLVENT;

ARTICLE; BRAIN TOXICITY; CLINICAL TRIAL; COGNITIVE REHABILITATION; COMPENSATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LAW SUIT; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; OBJECT RELATION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOSOCIAL REHABILITATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

COGNITIVE THERAPY; HUMANS; LINEAR MODELS; MALINGERING; MULTIVARIATE ANALYSIS; NEUROTOXICITY SYNDROMES; OCCUPATIONAL DISEASES; PATIENT SATISFACTION; SOLVENTS; TREATMENT OUTCOME;

EID: 45149131180     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000140088     Document Type: Article

References (41)

1. World Health Organization: Chronic effects of organic solvents on the central nervous system and diagnostic criteria. WHO, Copenhagen. Environmental Health 1985;5.
2. Baker EL, Seppäläinen AM: Workshop on neurobehavioral effects of solvents. Human aspects of solvent neurobehavioral effects. Neurotoxicology 1987;7:45-56.
3. Ridgway P, Nixon TE, Leach JP: Occupational exposure to organic solvents and long-term nervous system damage detectable by brain imaging, neurophysiology or histopathology. Food Chem Toxicol 2003;41:153-187.
4. World Health Organization: Operational guide for the WHO neurobehavioral core test battery. WHO Office of Occupational Health, Geneva, 1986.
5. Van Hout MSE, Schmand B, Wekking EM, Hageman G, Deelman BG: Malingering or suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy. Neurotoxicology 2003;24:547-551.
6. Van Hout MSE, Schmand B, Wekking EM, Deelman BG: Cognitive functioning in patients with suspected chronic toxic encephalopathy: evidence for neuropsychogical disturbances after controlling for insufficient effort. J Neurol Neurosurg Psychiatry 2006;77:296-303.
7. Orbaek P: Solvent-induced disability and recovery after cessation of exposure; in Chang LW, Dyer RS (eds): Handbook of Neurotoxicology. New York, Marcel Dekker Inc, 1995, pp 339-354.
8. Jensen PB, Mamsen P, Pedersen G: Memory training of patients with chronic toxic encephalopathy. Nord Psykiatr Tidsskr 1985;39:501-507.
9. Lindgren MS, Hagstadius S, Abjornsson G, Orbaek P: Neuropsychological rehabilitation of patients with organic solvent-induced chronic toxic Encephalopathy, a pilot study. Neuropsychol Rehabil 1997;7:1-22.
10. Abjornsson G, Orbaek P, Hagstadius S: Chronic toxic encephalopathy: social consequences and experiences from a rehabilitation program. Rehabil Nurs 1998;23:38-43.
11. Engel L, Andersen LB: Effects of body-mind training and relaxation stretching on persons with chronic toxic encephalopathy. Patient Educ Couns 2000;39:155-161.
12. Abjornson GL, Karlson BA, Orbaek PH: Education for men with solvent-induced chronic toxic encephalopathy and their spouses. Patient Educ Couns 2005;58:88-95.
13. Van Hout MSE, Wekking EM, Berg IJ, Deelman BG: Psychological treatment of patients with chronic toxic encephalopathy: lessons from studies of chronic fatigue and whiplash. Psychother Psychosom 2003;72:235-244.
14. Cicerone KD, Dahlberg C, Kalmar K, Langenbahn DM, Malec JF, Bergquist TF, Felicetti T, Giacino JT, Harley JP, Harrington DE, Herzog J, Kneipp S, Laatsch L, Morse PA: Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehabil 2000;81:1596-1615.
15. Berg I, Schmidt I: Cognitive rehabilitation of memory disorders;in Brouwer W, Van Zomeren E, Berg I, Bouma A, Haan E (eds): Cognitive Rehabilitation: a Clinical Approach. Amsterdam, Boom, 2002, pp 143-165.
16. Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-19.
17. Wise EA: Methods for analyzing psychotherapy outcomes: a review of clinical significance, reliable change, and recommendations for future directions. J Pers Assess 2004;82:50-59.
18. Van der Hoek JAF, Verberk MM, Van der Laan G, Hageman G: A protocol for the diagnosis of solvent-induced CTE, 2 years of experience. Neurotoxicology 2000;21:887.
19. Wekking EM, van Hout MSE, Emmen HH: The Dutch neuropsychological test battery for diagnosing CTE [abstract]. Neurotoxicology 2000;21:887-888.
20. Mulder JL, Dekker R, Dekker PH: Verbale Leer en Geheugen Test. (Dutch adaptation of the California Verbal Learning Test). Manual. Lisse, Swets & Zeitlinger, 1996.
21. Wilson B, Cockburn J, Baddeley A, Hiorns R: The Rivermead Behavioural Memory Test. Bury St Edmunds, Thames Valley Test Company, 1991.
22. Van Balen HGG, Wimmers MFHG: The Rivermead Behavioural Memory Test. Dutch and Flemish Norms. Lisse, Swets & Zeitlinger, 1993.
23. Berg IJ, Koning-Haanstra M, Deelman BG: Long-term effects of memory rehabilitation: A controlled study. Neuropsychol Rehab 1991;1:97-111.
24. Milders M, Deelman B, Berg I: Rehabilitation of memory for people's names. Memory 1998;6:21-36.
25. Schmidt IW, Dijkstra HT, Berg IJ, Deelman BG: Memory training for remembering names. Clin Gerontol 1999;20:57-73.
26. Tombaugh TM: TOMM Test of memory malingering, Manual. Toronto, Multi Health Systems, 1996.
27. Warrington EK: Recognition Memory Test, Manual. Windsor, Berkshire: NFER-Nelson, 1984.
28. Iverson GL, Frantzen MD: Detecting malingered memory deficits with the Facial Recognition Memory Test. Brain Injury 1998;12:275-282.
29. Bruin AF, Diederiks JPM, Witte LP, Stevens FCJ, Philipsen H: SIP-68. Een verkorte versie van de Sickness Impact Profile. Maastricht: RL, vakgroep Medische Sociologie, 1995.
30. Lindgren M: Neuropsychological studies of patients with organic solvent induced chronic toxic encephalopathy. Prognosis, personality characteristics, rehabilitation. PhD Dissertation Lund University, Sweden, 1992.
31. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
32. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-370.
33. Hooisma J, Hänninen H, Emmen HH, Kulig BM: Symptoms indicative of the effects of organic solvent exposure in Dutch painters. Neurotoxicol Teratol 1994;16:613-622.
34. Schreurs PJG, Van de Willige G, Brosschot JF, Tellegen B, Graus GMH: De Utrechtse Coping Lijst. Omgaan met problemen en gebeurtenissen. Manual. Lisse, Swets & Zeitlinger, 1993.
35. Van den Burg W, Saan RJ, Deelman BG: The 15-Words Test Manual. Dept. Neuropsychology, University of Groningen, 1985.
36. Deelman BG, Berg IJ: Evaluation of neuropsychological rehabilitation;in Brouwer W, Van Zomeren E, Berg I, Bouma A, Haan E (eds): Cognitive Rehabilitation: a Clinical Approach. Amsterdam, Boom, 2002, pp 269-286.
37. Berg IJ, Koning-Haanstra M, Deelman BG: Prediction of success of memory-strategy training: a randomized, long-term study. J Clin Exp Neuropsychol 1992;14:106.
38. Barr WB: Neuropsychological testing for assessment of treatment effects: methodologic issues. CNS Spectr 2002;7:300-302.
39. Lindeboom R, Vermeulen R, de Haan R: Klinimetrie;in Deelman BG, Eling P, de Haan E, van Zomeren E (eds): Klinische Neuropsychologie. Amsterdam, Boom, 2004.
40. Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C: Comparative responsiveness of generic and specific quality-of-life instruments, J Clin Epidemiol 2003;56:52-60.
41. Rockwood K, Joyce B, Stolee P: Use of goal attainment scaling in measuring clinically important change in cognitive rehabilitation patients. J Clin Epidemiol 1997;50:581-588.